2024 Annual Meeting | C61 - Neurologic Consultations in Cancer Patients

Date Sunday 04/14/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | 102/104/106

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Roy E. Strowd III, MD, FAAN

Topic(s) Neuro-oncology

Learning Objectives Participants should become familiar with common neurologic complications of systemic cancer and its treatment including surgery, radiation therapy, and chemotherapy; the evidence-based recommendations for managing patients with neurologic symptoms in the setting of primary brain tumors; and identify common diagnoses that mimic brain neoplasms.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:15 PM MDT	Speaker	Common Calls from the Cancer Center, Neurologic Symptoms in Patients with Systemic Malignancy Amy A. Pruitt, MD, FAAN
04:15 PM - 05:00 PM MDT	Speaker	Neurologic Syndromes in Late Survivors of Primary Brain Tumors Alyx B. Porter, MD, FAAN
05:00 PM - 05:30 PM MDT	Speaker	Putting It Altogether with a Case-based Review of Neurologic Complications in Cancer Patients Roy E. Strowd III, MD, FAAN

Faculty Disclosures
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Amy A. Pruitt, MD, FAAN	Dr. Pruitt has nothing to disclose.
Alyx B. Porter, MD, FAAN	Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.